Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) shares dropped 11% on Thursday . The company traded as low as $9.45 and last traded at $9.45. Approximately 400 shares were traded during trading, a decline of 76% from the average daily volume of 1,652 shares. The stock had previously closed at $10.62.
Nxera Pharma Trading Down 11.0 %
The stock has a fifty day moving average price of $9.90 and a two-hundred day moving average price of $9.83.
About Nxera Pharma
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Featured Stories
- Five stocks we like better than Nxera Pharma
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- Breakout Stocks: What They Are and How to Identify Them
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
